08:00 , Dec 14, 2015 |  BioCentury  |  Product Development

Following CoMMpass

Amidst a flood of promising data for hot targets, indications and technologies at this year's American Society of Hematology meeting, one collection of presentations stands out not only for the wide-reaching implications of their data,...
07:00 , Apr 23, 2012 |  BC Week In Review  |  Company News

Abbott, Stanford University deal

The university granted Abbott an exclusive license for biomarkers to develop a molecular diagnostic test to differentiate aggressive and non-aggressive prostate cancer. Abbott will develop an assay based on its fluorescence in situ hybridization (FISH)...